1019 related articles for article (PubMed ID: 18337605)
1. EGFR antagonists in cancer treatment.
Ciardiello F; Tortora G
N Engl J Med; 2008 Mar; 358(11):1160-74. PubMed ID: 18337605
[No Abstract] [Full Text] [Related]
2. Epidermal growth factor receptor targeted therapies for solid tumours.
Van den Eynde M; Baurain JF; Mazzeo F; Machiels JP
Acta Clin Belg; 2011; 66(1):10-7. PubMed ID: 21485758
[TBL] [Abstract][Full Text] [Related]
3. Exploring the future of non-small cell lung cancer treatment.
Ramalingam S
Manag Care; 2005 Feb; 14(2 Suppl):9-13; discussion 13-4. PubMed ID: 15776956
[No Abstract] [Full Text] [Related]
4. EGFR-directed therapies to treat non-small-cell lung cancer.
Ho C; Laskin J
Expert Opin Investig Drugs; 2009 Aug; 18(8):1133-45. PubMed ID: 19572809
[TBL] [Abstract][Full Text] [Related]
5. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
Jänne PA; Johnson BE
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4416s-4420s. PubMed ID: 16857820
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
Venook AP
Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
[TBL] [Abstract][Full Text] [Related]
7. Targeting HER1/EGFR: pathway to progress in cancer therapy.
Oncology (Williston Park); 2007 Dec; 21(14):2 p preceding 1754. PubMed ID: 18247019
[No Abstract] [Full Text] [Related]
8. Predictive tests for EGFR inhibitors.
Lynch TJ
Clin Adv Hematol Oncol; 2005 Sep; 3(9):678-9. PubMed ID: 16224439
[No Abstract] [Full Text] [Related]
9. FGFR as potential target in the treatment of squamous non small cell lung cancer.
Tiseo M; Gelsomino F; Alfieri R; Cavazzoni A; Bozzetti C; De Giorgi AM; Petronini PG; Ardizzoni A
Cancer Treat Rev; 2015 Jun; 41(6):527-39. PubMed ID: 25959741
[TBL] [Abstract][Full Text] [Related]
10. [Basic principles of signal transduction].
Yarden Y
Onkologie; 2005 Oct; 28 Suppl 4():14-7. PubMed ID: 16205100
[No Abstract] [Full Text] [Related]
11. A systems pharmacology approach to improve drug therapy in NSCLC: establishing a CESAR network.
Kalayda GV; Michaelis M; Cinatl J; Mader RM; Fröhlich H; Sarin N; Melin J; Engel F; Jäger W; Frötschl R; Jaehde U; Kloft C; Ritter CA
Int J Clin Pharmacol Ther; 2014 Jan; 52(1):89-91. PubMed ID: 24216144
[No Abstract] [Full Text] [Related]
12. Targeting the target: a step forward for the treatment of non-small-cell lung cancer.
Douillard JY
Lancet Oncol; 2010 Feb; 11(2):104-5. PubMed ID: 20152760
[No Abstract] [Full Text] [Related]
13. [Theoretical background of cancer treatment targeting EGF-R signal transduction pathways].
Daniel P; Małecka-Panas E
Przegl Lek; 2005; 62(8):804-9. PubMed ID: 16521502
[TBL] [Abstract][Full Text] [Related]
14. [Isolation regional perfusion].
Guadagni S; D'Alessandro V; Marsili L; Palumbo G; Franchi L; Sozio A; Mazzotta C; Amicucci G
Suppl Tumori; 2002; 1(3):S32-4. PubMed ID: 12415784
[No Abstract] [Full Text] [Related]
15. Black cellular spreading and motility assay.
al Moustafa AE; Urbani N; O'Connor-McCourt M
Biotechniques; 1999 Jul; 27(1):60-2. PubMed ID: 10407664
[No Abstract] [Full Text] [Related]
16. Talking with patients about dying.
Smith TJ; Longo DL
N Engl J Med; 2013 Jan; 368(5):481. PubMed ID: 23373069
[No Abstract] [Full Text] [Related]
17. Talking with patients about dying.
Pao M; Wiener L; Zadeh S
N Engl J Med; 2013 Jan; 368(5):480. PubMed ID: 23363511
[No Abstract] [Full Text] [Related]
18. Talking with patients about dying.
Hughes-Davies T
N Engl J Med; 2013 Jan; 368(5):480. PubMed ID: 23363510
[No Abstract] [Full Text] [Related]
19. Talking with patients about dying.
Singh G
N Engl J Med; 2013 Jan; 368(5):479-80. PubMed ID: 23363509
[No Abstract] [Full Text] [Related]
20. Talking with patients about dying.
Weinfurt KP; Kim SY; Meropol NJ
N Engl J Med; 2013 Jan; 368(5):479. PubMed ID: 23363508
[No Abstract] [Full Text] [Related]
[Next] [New Search]
